Cementos Bio Bio Statistics
Total Valuation
Cementos Bio Bio has a market cap or net worth of CLP 186.28 billion. The enterprise value is 304.61 billion.
Market Cap | 186.28B |
Enterprise Value | 304.61B |
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024.
Earnings Date | Nov 27, 2024 |
Ex-Dividend Date | Sep 23, 2024 |
Share Statistics
Cementos Bio Bio has 264.22 million shares outstanding. The number of shares has increased by 0.17% in one year.
Shares Outstanding | 264.22M |
Shares Change (YoY) | +0.17% |
Shares Change (QoQ) | -3.25% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 10.92% |
Float | 46.70M |
Valuation Ratios
The trailing PE ratio is 5.67.
PE Ratio | 5.67 |
Forward PE | n/a |
PS Ratio | 0.52 |
PB Ratio | 0.67 |
P/FCF Ratio | 5.50 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.75, with an EV/FCF ratio of 9.00.
EV / Earnings | 9.26 |
EV / Sales | 0.84 |
EV / EBITDA | 4.75 |
EV / EBIT | 7.14 |
EV / FCF | 9.00 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 47.97.
Current Ratio | 1.59 |
Quick Ratio | 0.80 |
Debt / Equity | 47.97 |
Debt / EBITDA | 2.05 |
Debt / FCF | 3.89 |
Interest Coverage | 3.37 |
Financial Efficiency
Return on equity (ROE) is 12.58% and return on invested capital (ROIC) is 6.84%.
Return on Equity (ROE) | 12.58% |
Return on Assets (ROA) | 5.43% |
Return on Capital (ROIC) | 6.84% |
Revenue Per Employee | 322.30M |
Profits Per Employee | 29.40M |
Employee Count | 1,142 |
Asset Turnover | 0.73 |
Inventory Turnover | 3.68 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.97% in the last 52 weeks. The beta is 0.16, so Cementos Bio Bio's price volatility has been lower than the market average.
Beta (5Y) | 0.16 |
52-Week Price Change | +5.97% |
50-Day Moving Average | 705.10 |
200-Day Moving Average | 685.60 |
Relative Strength Index (RSI) | 100.00 |
Average Volume (20 Days) | 665 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cementos Bio Bio had revenue of CLP 360.65 billion and earned 32.90 billion in profits. Earnings per share was 124.31.
Revenue | 360.65B |
Gross Profit | 139.74B |
Operating Income | 42.66B |
Pretax Income | 40.56B |
Net Income | 32.90B |
EBITDA | 53.50B |
EBIT | 42.66B |
Earnings Per Share (EPS) | 124.31 |
Balance Sheet
The company has 14.02 billion in cash and 131.69 billion in debt, giving a net cash position of -117.66 billion or -445.31 per share.
Cash & Cash Equivalents | 14.02B |
Total Debt | 131.69B |
Net Cash | -117.66B |
Net Cash Per Share | -445.31 |
Equity (Book Value) | 274.51B |
Book Value Per Share | 1,050.13 |
Working Capital | 53.24B |
Cash Flow
In the last 12 months, operating cash flow was 50.63 billion and capital expenditures -16.79 billion, giving a free cash flow of 33.85 billion.
Operating Cash Flow | 50.63B |
Capital Expenditures | -16.79B |
Free Cash Flow | 33.85B |
FCF Per Share | 128.10 |
Margins
Gross margin is 38.75%, with operating and profit margins of 11.83% and 9.12%.
Gross Margin | 38.75% |
Operating Margin | 11.83% |
Pretax Margin | 11.25% |
Profit Margin | 9.12% |
EBITDA Margin | 14.83% |
EBIT Margin | 11.83% |
FCF Margin | 9.38% |
Dividends & Yields
This stock pays an annual dividend of 36.00, which amounts to a dividend yield of 5.11%.
Dividend Per Share | 36.00 |
Dividend Yield | 5.11% |
Dividend Growth (YoY) | 200.00% |
Years of Dividend Growth | n/a |
Payout Ratio | 28.87% |
Buyback Yield | -0.17% |
Shareholder Yield | 4.93% |
Earnings Yield | 17.63% |
FCF Yield | 18.17% |
Stock Splits
The last stock split was on July 17, 1995. It was a forward split with a ratio of 10.
Last Split Date | Jul 17, 1995 |
Split Type | Forward |
Split Ratio | 10 |